Dissociation of amyloid biomarkers in PET and CSF in Alzheimer’s disease: a case report

BACKGROUND: Recently, biomarkers have been suggested to be incorporated into diagnostic criteria for Alzheimer’s disease (AD). Regarding disease-specific brain amyloid-beta deposition these comprise low amyloid-beta 1–42 in cerebrospinal fluid (CSF) and positive positron emission tomography (PET) am...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Neurol
Main Authors: Schroeter, Matthias L., Tiepolt, Solveig, Marschhauser, Anke, Thöne-Otto, Angelika, Hoffmann, Karl-Titus, Barthel, Henryk, Obrig, Hellmuth, Sabri, Osama
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2015
Assuntos:
Case Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4548309/
https://ncbi.nlm.nih.gov/pubmed/26303364
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-015-0410-5
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares